FY2025 · period end Dec '25 · from the 10-K filed Feb 24, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $6.38B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000914208-26-000207 | Jul 10, 2026 | Jul 10, 2026 | Jul 10, 2026 08:01 UTC | EDGAR |
| 8-K | 0000914208-26-000202 | Jun 9, 2026 | Jun 9, 2026 | Jun 9, 2026 20:20 UTC | EDGAR |
| 8-K | 0000914208-26-000196 | May 21, 2026 | May 22, 2026 | May 22, 2026 20:19 UTC | EDGAR |
| 8-K | 0000914208-26-000191 | May 11, 2026 | May 11, 2026 | May 11, 2026 20:22 UTC | EDGAR |
| 10-Q | 0000914208-26-000106 | Mar 31, 2026 | May 5, 2026 | May 5, 2026 18:09 UTC | EDGAR |
| 8-K | 0000914208-26-000102 | Apr 28, 2026 | Apr 28, 2026 | Apr 28, 2026 10:56 UTC | EDGAR |
| 8-K | 0000914208-26-000097 | Apr 10, 2026 | Apr 10, 2026 | Apr 10, 2026 12:04 UTC | EDGAR |
| 8-K | 0000914208-26-000088 | Mar 10, 2026 | Mar 10, 2026 | Mar 10, 2026 20:19 UTC | EDGAR |
Direct links to SEC EDGAR. IVZ has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Cash Provided by (Used in) Operating Activities·FY 2016
Major restatementwas$129.3M
Revised up in a 10-K. Any P/OCF built on the original was 80.2% too high.
Net Cash Provided by (Used in) Operating Activities·Q2 2009
Major restatementwas-$28.6M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q1 2017
Major restatementwas$315.9M
Revised down in a 10-Q. Any P/OCF built on the original was 149.7% too low.
Net Cash Provided by (Used in) Operating Activities·Q1 2016
Major restatementwas-$68.8M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q2 2017
Major restatementwas$781.6M
Revised down in a 10-Q. Any P/OCF built on the original was 104.0% too low.
Net Cash Provided by (Used in) Operating Activities·Q3 2017
Major restatementwas$1B
Revised down in a 10-Q. Any P/OCF built on the original was 30.9% too low.
IVZ is not the only one.
See every restatement we've found across the market — or get an alert the next time IVZ revises a number.
Restatements are detected by comparing every vintage of a fact across all of Invesco Ltd.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows IVZ's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Invesco Ltd. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on IVZ yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on IVZ and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $5.72B |
| $6.05B |
| $6.89B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | negative: -$0.70B | $0.83B | negative: -$0.43B | $1.32B | $1.79B |
|---|
| Net Income | — | $0.54B | negative: -$0.33B | $0.68B | $1.39B |
|---|
| EPS (Diluted) | negative: -$1.60 | $1.18 | negative: -$0.73 | $1.49 | $2.99 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $27.09B | $27.01B | $28.93B | $29.76B | $32.69B |
| Total Liabilities | $14.09B | $11.34B | $13.02B | $12.91B | $16.01B |
| Stockholders' Equity | $12.93B | $15.12B | $15.17B | $15.84B | $16.17B |
| Cash & Equivalents | $1.04B | $1.50B | $1.47B | $1.43B | $2.15B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.53B | $1.19B | $1.30B | $0.70B | $1.08B |
| Capital Expenditures | $0.08B | $0.07B | $0.16B | $0.19B | $0.11B |
| Free Cash Flow | $1.44B | $1.12B | $1.14B | $0.51B | $0.97B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | negative: -0.1% | 0.1% | negative: -0.1% | 0.2% | 0.3% |
| Net Margin | negative: -0.1% | 0.1% | negative: -0.1% | 0.1% | 0.2% |
| Return on Equity | negative: -3.3% | 3.6% | negative: -2.2% | 4.3% | 9.0% |
| Return on Assets | negative: -1.7% | 1.9% | negative: -1.1% | 2.2% | 4.0% |
| Debt / Equity | 0.14× | 0.06× | 0.10× | 0.09× | 0.13× |
